"Methadone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
| Descriptor ID |
D008691
|
| MeSH Number(s) |
D02.522.675
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Methadone".
Below are MeSH descriptors whose meaning is more specific than "Methadone".
This graph shows the total number of publications written about "Methadone" by people in this website by year, and whether "Methadone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 3 | 4 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 2 | 4 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methadone" by people in Profiles.
-
Balise RR, Hu MC, Calderon AR, Odom GJ, Brandt L, Luo SX, Feaster DJ. Data cleaning and harmonization of clinical trial data: Medication-assisted treatment for opioid use disorder. PLoS One. 2024; 19(11):e0312695.
-
Morales P, Santiago L, Rosario J, Garcia-Fragoso L, Duconge J, Perez N, Santiago D. Neonatal Abstinence Syndrome and Corresponding Pharmacotherapy Approaches from 2 University-affiliated Neonatal Intensive Care Units in Puerto Rico (2018-2020). P R Health Sci J. 2024 Mar; 43(1):25-31.
-
L?pez-Castro T, Jakubowski A, Masyukova M, Peterson M, Pierz A, Kodali S, Arnsten JH, Starrels JL, Nahvi S. Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic. J Subst Use Addict Treat. 2024 02; 157:209235.
-
Brandt L, Hu MC, Liu Y, Castillo F, Odom GJ, Balise RR, Feaster DJ, Nunes EV, Luo SX. Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder. Am J Psychiatry. 2023 05 01; 180(5):386-394.
-
Syvertsen JL, Toneff H, Howard H, Spadola C, Madden D, Clapp J. Conceptualizing stigma in contexts of pregnancy and opioid misuse: A qualitative study with women and healthcare providers in Ohio. Drug Alcohol Depend. 2021 05 01; 222:108677.
-
Pro G, Utter J, Haberstroh S, Baldwin JA. Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year. Drug Alcohol Depend. 2020 04 01; 209:107952.
-
Glenn MC, Sohler NL, Starrels JL, Maradiaga J, Jost JJ, Arnsten JH, Cunningham CO. Characteristics of methadone maintenance treatment patients prescribed opioid analgesics. Subst Abus. 2016 Jul-Sep; 37(3):387-391.
-
Sohler NL, Weiss L, Egan JE, L?pez CM, Favaro J, Cordero R, Cunningham CO. Consumer attitudes about opioid addiction treatment: a focus group study in New York City. J Opioid Manag. 2013 Mar-Apr; 9(2):111-9.
-
Nyamathi A, Albarr?n CR, Branson C, Marfisee M, Khalilifard F, Leake B. Correlates of depressive symptoms among alcohol-using methadone maintained adults. Am J Addict. 2012 Nov; 21 Suppl 1:S49-55.
-
McLemore GL, Lewis T, Jones CH, Gauda EB. Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome. Semin Fetal Neonatal Med. 2013 Feb; 18(1):35-41.